North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 30 of 41
Older
Oldest
Details
UPD
sitematrix Changed from 0 to
29/04/2024 13:01:01
(DavidS )
UPD
FurtherInformation Changed from
0.25mg/0.19mL, 0.5mg/0.37mL and 1mg/0.7mL solution for injection pre-filled pen (
Ozempic®
)
Approved for the treatment of type 2 diabetes in patients who require an intensifica
29/04/2024 13:01:01
(DavidS )
UPD
Semaglutide added line regarding ICS to entry
29/04/2024 13:01:01
(DavidS )
UPD
sitematrix Changed from 0 to
20/03/2024 15:39:15
(DavidS )
UPD
FurtherInformation Changed from
0.25mg/0.19mL, 0.5mg/0.37mL and 1mg/0.7mL solution for injection pre-filled pen (
Ozempic®
)
Approved for the treatment of type 2 diabetes in patients who require an intensifica
20/03/2024 15:39:15
(DavidS )
UPD
Semaglutide added Red to Wegovy
20/03/2024 15:39:15
(DavidS )
UPD
Published from Draft Mode
20/03/2024 15:38:43
(DavidS )
LDL
Link Added : NICE TA875: Semaglutide for managing overweight and obesity : https://www.nice.org.uk/guidance/ta875
11/03/2024 13:21:28
(DavidS )
UPD
sitematrix Changed from 0 to
11/03/2024 13:15:00
(DavidS )
UPD
isDraft Changed from N to Y
11/03/2024 13:15:00
(DavidS )
UPD
drugExtra Changed from GLP1 agonist to
11/03/2024 13:15:00
(DavidS )
UPD
FurtherInformation Changed from
0.25mg/0.19mL, 0.5mg/0.37mL and 1mg/0.7mL solution for injection pre-filled pen (Ozempic®)
Approved for the treatment of type 2 diabetes in patients who require an intensification in treatment
11/03/2024 13:15:00
(DavidS )
UPD
Semaglutide combined Wegovy to only have semaglutide entry
11/03/2024 13:15:00
(DavidS )
UPD
sitematrix Changed from 0 to
31/01/2024 13:20:13
(DavidS )
UPD
FurtherInformation Changed from
0.25mg/0.19mL, 0.5mg0.37mL and 1mg/0.7mL solution for injection pre-filled pen (Ozempic®)
Approved for the treatment of type 2 diabetes in patients who require an intensification in treatment<
31/01/2024 13:20:13
(DavidS )
UPD
Semaglutide amended typo
31/01/2024 13:20:13
(DavidS )
LDL
Link Added : National Patient Safety Alert - Shortage of GLP-1 receptor agonists (GLP-1 RA) update : https://www.cas.mhra.gov.uk/ViewandAcknowledgment/ViewAttachment.aspx?Attachment id=104161
30/01/2024 15:03:05
(DavidS )
DUP
Item ID 5487 : Moved from 06.01.02.03 to 06.01.02.03
30/01/2024 14:55:01
(DavidS )
UPD
sitematrix Changed from 0 to
10/07/2023 15:03:02
(dmcdermott )
UPD
drugExtra Changed from to GLP1 agonist
10/07/2023 15:03:02
(dmcdermott )
UPD
Semaglutide #
10/07/2023 15:03:02
(dmcdermott )
UPD
sitematrix Changed from 0 to
14/06/2023 11:27:43
(rpaylor )
UPD
FurtherInformation Changed from
0.25mg/0.19mL, 0.5mg0.37mL and 1mg/0.7mL solution for injection pre-filled pen (Ozempic®)
Approved for the treatment of type 2 diabetes in patients who require an intensification in treatment<
14/06/2023 11:27:43
(rpaylor )
UPD
Semaglutide black triangle
14/06/2023 11:27:43
(rpaylor )
UPD
sitematrix Changed from 0 to
19/10/2022 11:28:43
(DavidS )
UPD
FurtherInformation Changed from
0.25mg/0.19mL, 0.5mg0.37mL and 1mg/0.7mL solution for injection pre-filled pen (Ozempic®)
Approved for the treatment of type 2 diabetes in patients who require an intensification in t
19/10/2022 11:28:43
(DavidS )
UPD
Semaglutide updated formatting
19/10/2022 11:28:43
(DavidS )
UPD
sitematrix Changed from 0 to
26/04/2022 12:58:42
(DavidS )
UPD
FurtherInformation Changed from
0.25mg/0.19mL, 0.5mg0.37mL and 1mg/0.7mL solution for injection pre-filled pen (Ozempic®)
Approved for the treatment of type 2 diabetes in patients who require an intensification in t
26/04/2022 12:58:42
(DavidS )
UPD
Semaglutide updated
26/04/2022 12:58:42
(DavidS )
